Company Filing History:
1 out of 107 
1 out of 832,891 Years Active: 2023
Title: Innovator Yuma Ishida: Advancing Cardiovascular Diagnostics
Introduction: Yuma Ishida, an accomplished inventor based in Fukuoka, Japan, has made strides in the field of cardiovascular health. With a keen focus on innovative diagnostic tools, Ishida has secured a patent that contributes significantly to the understanding and detection of specific states of low-density lipoproteins (LDL), which are crucial in assessing cardiovascular risk.
Latest Patents: Ishida holds a notable patent titled "Detection reagents and kit for identifying oxidized state and glycated state of low-density lipoproteins." The invention presents a comprehensive approach to detecting both oxidized and glycated states of LDL. This is achieved using a fluoro-phore labelled antibody for detecting the oxidized form, while a fluorescent nitroxide, specifically 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD-Pen), is used for lipid radical detection. This innovative reagent kit has potential implications for improving cardiovascular diagnostics.
Career Highlights: Throughout his career, Yuma Ishida has gained valuable experience working with various institutions, including Fuso Pharmaceutical Industries, Ltd. His contributions to the field of health diagnostics have positioned him as a significant figure in medical innovation.
Collaborations: Ishida has collaborated with esteemed colleagues such as Ken-ichi Yamada and Tomomi Ide. Their teamwork has fostered a dynamic research environment, leading to advancements in the development of innovative diagnostic techniques.
Conclusion: Yuma Ishida’s patent for a detection reagent signifies a pivotal step toward enhanced cardiovascular diagnostics. With his dedication to medical innovation, combined with collaborative efforts from his colleagues, Ishida continues to contribute meaningfully to the field, ultimately benefiting patient care and health outcomes.